Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Masayuki,Kurosaki

第一单位： Divisions of Gastroenterology and Hepatologym, Musashino Red Cross Hospital, Tokyo.

作者： Masayuki,Kurosaki ^[1] ; Takanori,Hosokawa ; Kotaro,Matsunaga ; Itsuko,Hirayama ; Tomohiro,Tanaka ; Mitsuaki,Sato ; Yutaka,Yasui ; Nobuharu,Tamaki ; Ken,Ueda ; Kaoru,Tsuchiya ; Teiji,Kuzuya ; Hiroyuki,Nakanishi ; June,Itakura ; Yuka,Takahashi ; Yasuhiro,Asahina ; Nobuyuki,Enomoto ; Namiki,Izumi

作者单位： Divisions of Gastroenterology and Hepatologym, Musashino Red Cross Hospital, Tokyo. ^[1]

DOI 10.1111/j.1872-034X.2010.00692.x

PMID 20887591

发布时间 2022-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览18

Hepatology research

2010年40卷9期

870-7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.

Hepatology research

相似文献

Hepatology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy.

Hepatology research

相似文献

Hepatology research

相关期刊

检索历史清除